✦ LIBER ✦

A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma

✍ Scribed by Jeeyun Lee; Young-Hyuck Im; Eun Yoon Cho; Yong Sang Hong; Hyo Rak Lee; Hyo Song Kim; Mi-Jin Kim; Kwhanmien Kim; Won Ki Kang; Keunchil Park; Young Mog Shim

Publisher: Springer
Year: 2007
Tongue: English
Weight: 268 KB
Volume: 62
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-007-0577-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of capecitabine and cispl

Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma

✍ Yu-Hong Li; Feng-Hua Wang; Wen-Qi Jiang; Xiao-Juan Xiang; Yan-Ming Deng; Guo-Qin 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 256 KB

Phase I/II study of a combination of doc

Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer

✍ Yoon-Koo Kang; Min-Hee Ryu; Changhoon Yoo; Heung-Moon Chang; Jeong Hwan Yook; Su 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 334 KB

Phase II study of irinotecan as first-li

Phase II study of irinotecan as first-line chemotherapy for patients with advanced colorectal carcinoma

✍ José Luis Fírvida; Antonio Irigoyen; Sergio Vázquez-Estévez; Pilar Díz; Manuel C 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

A multi-center phase II study of docetax

A multi-center phase II study of docetaxel plus cisplatin as first-line therapy in patients with metastatic squamous cell esophageal cancer

✍ Jin Young Kim; Young Rok Do; Keon Uk Park; Min Kyung Kim; Kyung Hee Lee; Sung Hw 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 200 KB

Docetaxel/cisplatin as first-line chemot

Docetaxel/cisplatin as first-line chemotherapy in patients with head and neck carcinoma : A Phase II trial

✍ Martina Baur; Heinz-Roland Kienzer; Johannes Schweiger; Maria DeSantis; Erich Ge 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this Phase II study was to assess the clinical activity and toxicity of docetaxel (D) and cisplatin (P) in patients with locally advanced unresectable, metastatic, or recurrent squamous cell carcinoma of the head and neck (SCCHN). ## PATIENTS Of 34 pati

Mitomycin-C and capecitabine as third-li

Mitomycin-C and capecitabine as third-line chemotherapy in patients with advanced colorectal cancer: a phase II study

✍ Do Hyoung Lim; Young Suk Park; Byeong-Bae Park; Sang Hoon Ji; Jeeyun Lee; Keon W 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 200 KB